CSIMarket
 


Cytosorbents Corp  (CSTO)
Other Ticker:  
 
 

CSTO's Income from Cont. Operations Growth by Quarter and Year

Cytosorbents's Income from Cont. Operations results by quarter and year




CSTO Income from Cont. Operations (in millions $) FY 2013 FY 2012 FY 2011 FY 2010
IV Quarter December - 0.00 0.00 0.00
III Quarter September -0.96 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -0.96 0.00 0.00 0.00



CSTO Income from Cont. Operations third quarter 2013 Y/Y Growth Comment
Cytosorbents Corp in the third quarter 2013 recorded loss from continued operations of $ -0.96 millions.

According to the results reported in the third quarter 2013, Cytosorbents Corp achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While Cytosorbents Corp' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2013.




CSTO Income from Cont. Operations ( Y/Y Growth %) 2013
2012 2011 2010
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cytosorbents's third quarter 2013 Income from Cont. Operations $ -0.96 millions CSTO's Income Statement
Cytosorbents's third quarter 2012 Income from Cont. Operations $ 0.00 millions Quarterly CSTO's Income Statement
New: More CSTO's historic Income from Cont. Operations Growth >>


CSTO Income from Cont. Operations (Quarter on Quarter Growth %)

2013
2012 2011 2010
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2013 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2013 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2010, 2011, 2012, 2013

Cytosorbents's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CSTO's III. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CSTO's III. Quarter Q/Q Income from Cont. Operations Comment


Cytosorbents's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2013)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ -0.96 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Cytosorbents Corp' has realized cumulative trailing twelve months loss from continued operations of $ -1 millions in the Sep 30 2013 period.
The results are worsening as the cumulative loss from continued operations is inflating from $ 0 millions in the twelve months ending a quarter before and $ millions from the TTM period ending Stephanie V. Campbell told.

Cytosorbents Corp achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Cytosorbents Corp' has realized cumulative trailing twelve months loss from continued operations of $ -1 millions in the Sep 30 2013 period.
The results are detiriorating as the cumulative loss from continued operations is inflating from $ 0 millions for the period from to and $ millions for the twelve months ending in the quarter Stephanie V. Campbell wrote.

Cytosorbents Corp achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
CSTO's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for CSTO's Competitors
Income from Cont. Operations Growth for Cytosorbents's Suppliers
Income from Cont. Operations Growth for CSTO's Customers

You may also want to know
CSTO's Annual Growth Rates CSTO's Profitability Ratios CSTO's Asset Turnover Ratio CSTO's Dividend Growth
CSTO's Roe CSTO's Valuation Ratios CSTO's Financial Strength Ratios CSTO's Dividend Payout Ratio
CSTO's Roa CSTO's Inventory Turnover Ratio CSTO's Growth Rates CSTO's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2013 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2013
Waters Corp-1.07%$ -1.071 millions
Varian Medical Systems Inc -2.37%$ -2.374 millions
Msa Safety Incorporated-2.41%$ -2.407 millions
Utah Medical Products Inc-5.51%$ -5.513 millions
Davita Inc -5.59%$ -5.592 millions
Brainstorm Cell Therapeutics inc -5.91%$ -5.913 millions
Global Cord Blood Corp-6.17%$ -6.174 millions
Baxter International Inc -6.69%$ -6.690 millions
Beam Therapeutics Inc -7.42%$ -7.415 millions
Eli Lilly And Company-9.31%$ -9.310 millions
Icu Medical Inc-9.47%$ -9.468 millions
Akorn Inc-11.26%$ -11.256 millions
Celgene Corp-12.18%$ -12.178 millions
Lhc Group Inc -12.96%$ -12.962 millions
Intuitive Surgical Inc -14.46%$ -14.457 millions
Chemed Corporation-16.37%$ -16.373 millions
Medicines Co-16.39%$ -16.386 millions
Pfizer Inc-16.91%$ -16.914 millions
United Therapeutics Corporation-19.75%$ -19.749 millions
Ensign Group Inc-19.95%$ -19.949 millions
Lifevantage Corp-21.82%$ -21.825 millions
Synthorx, Inc.-22.06%$ -22.061 millions
Acorda Therapeutics Inc -22.07%$ -22.066 millions
Merit Medical Systems Inc-22.41%$ -22.405 millions
Nature s Sunshine Products inc -23.86%$ -23.862 millions
Mylan N v -24.78%$ -24.780 millions
Steris Plc-25.91%$ -25.911 millions
Regeneron Pharmaceuticals Inc -26.20%$ -26.199 millions
Bard C R Inc-27.92%$ -27.920 millions
Magellan Health inc -28.72%$ -28.719 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com